Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss
- PMID: 24596404
- DOI: 10.1136/archdischild-2013-305276
Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss
Abstract
Background: Congenital cytomegalovirus (cCMV) is the most common non-genetic cause of sensorineural hearing loss (SNHL) in children. Ganciclovir has been shown to prevent the continued deterioration in hearing of children with symptomatic cCMV, but some children with cCMV-related SNHL are unidentified in the neonatal treatment period. Neonatal cCMV screening provides an opportunity to identify infants with cCMV-related SNHL who might benefit from early treatment.
Objectives: To assess the feasibility (ability to take samples before 3 weeks of age and clinical assessment by 30 days of age) and acceptability (maternal anxiety) of targeted CMV testing of infants who are 'referred' for further audiological testing after routine newborn hearing screening programme (NHSP).
Methods: Parents of infants who have 'no clear responses' on routine NHSP before 22 days of life in London and North East England were approached. Salivary and urine samples were tested by CMV PCR. At recruitment and 3 months, the short form Spielberger State-Trait Anxiety Inventory measured maternal anxiety.
Results: 411 infants were recruited. 99% (407/411) returned a sample; 98% (404/411) successfully yielded a CMV result, 6 had cCMV, all diagnosed on salivary samples taken <22 days of age (1.5%; 95% CI 0.6% to 3.2%). Only 50% returned urine samples compared with 99% returning salivary samples (p<0.001). Using saliva swabs 98% were successfully screened for CMV within 3 weeks. All positive screening CMV results were known by day 23, and 5/6 infants with cCMV were assessed within 31 days. Anxiety was not increased in mothers of infants screened for cCMV.
Conclusions: Targeted salivary screening for cCMV within the NHSP is feasible, acceptable and detects infants with cCMV-related SNHL who could benefit from early treatment.
Keywords: CMV; Congenital cytomegalovirus; deafness; screening; sensorineural hearing loss.
Similar articles
-
First estimates of the potential cost and cost saving of protecting childhood hearing from damage caused by congenital CMV infection.Arch Dis Child Fetal Neonatal Ed. 2015 Nov;100(6):F501-6. doi: 10.1136/archdischild-2014-306756. Epub 2015 Jun 29. Arch Dis Child Fetal Neonatal Ed. 2015. PMID: 26122458
-
Contribution of targeted saliva screening for congenital CMV-related hearing loss in newborns who fail hearing screening.Arch Dis Child Fetal Neonatal Ed. 2017 Nov;102(6):F519-F524. doi: 10.1136/archdischild-2016-311859. Epub 2017 May 3. Arch Dis Child Fetal Neonatal Ed. 2017. PMID: 28468898
-
Clinically targeted screening for congenital CMV - potential for integration into the National Hearing Screening Programme.Acta Paediatr. 2013 Oct;102(10):928-33. doi: 10.1111/apa.12335. Epub 2013 Aug 8. Acta Paediatr. 2013. PMID: 23927434
-
From diagnosis to management: current perspectives on congenital cytomegalovirus infection.Curr Opin Infect Dis. 2024 Aug 1;37(4):232-237. doi: 10.1097/QCO.0000000000001023. Epub 2024 May 14. Curr Opin Infect Dis. 2024. PMID: 38748563 Review.
-
Congenital cytomegalovirus: what the otolaryngologist should know.Curr Opin Otolaryngol Head Neck Surg. 2014 Dec;22(6):495-500. doi: 10.1097/MOO.0000000000000104. Curr Opin Otolaryngol Head Neck Surg. 2014. PMID: 25222916 Review.
Cited by
-
Evaluating the feasibility of integrating salivary testing for congenital CMV into the Newborn Hearing Screening Programme in the UK.Eur J Pediatr. 2015 Aug;174(8):1117-21. doi: 10.1007/s00431-015-2506-8. Epub 2015 Mar 7. Eur J Pediatr. 2015. PMID: 25743117
-
Hearing loss in children with congenital cytomegalovirus infection: an 11-year retrospective study based on laboratory database of a tertiary paediatric hospital.Acta Otorhinolaryngol Ital. 2019 Feb;39(1):40-45. doi: 10.14639/0392-100X-2020. Acta Otorhinolaryngol Ital. 2019. PMID: 30936577 Free PMC article.
-
Etiology of Prelingual Hearing Loss in the Universal Newborn Hearing Screening Era: A Scoping Review.Otolaryngol Head Neck Surg. 2020 Oct;163(4):662-670. doi: 10.1177/0194599820921870. Epub 2020 May 19. Otolaryngol Head Neck Surg. 2020. PMID: 32423335 Free PMC article.
-
Should You Follow the Better-Hearing Ear for Congenital Cytomegalovirus Infection and Isolated Sensorineural Hearing Loss?Otolaryngol Head Neck Surg. 2020 Jan;162(1):114-120. doi: 10.1177/0194599819880348. Epub 2019 Oct 8. Otolaryngol Head Neck Surg. 2020. PMID: 31593522 Free PMC article.
-
Newborn Screening for Congenital Cytomegalovirus (cCMV) Infection: Universal, Targeted, Expanded-Targeted, or None-of-the-Above?Neonatol Today. 2024 Aug;19(8):3-12. Neonatol Today. 2024. PMID: 39445079 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical